Concepedia
Statistics
Publications
13
Citations
612
H-Index
12
Active since
2010
Affiliations
Harvard University(Current)
Massachusetts General Hospital
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center
Dana-Farber Brigham Cancer Center
Amy Comander is an author at Harvard University specializing in oncology, medicine, and breast oncology.
Publications per year
2010–2025
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update
Neelima Denduluri, Mark R. Somerfield, Mariana Chávez‐MacGregor et al. · Journal of Clinical Oncology · 2020 · 101 citations
Medicine, Oncology, Breast Oncology +16
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features
Nadine Tung, Yihong Wang, Laura C. Collins et al. · Breast Cancer Research · 2010 · 92 citations · Full text
Medicine, Cancer Biology, Oncology +17
Clinical outcome of triple negative breast cancer in <i>BRCA1</i> mutation carriers and noncarriers
Larissa J. Lee, Brian M. Alexander, Stuart J. Schnitt et al. · Cancer · 2011 · 79 citations · Full text
Medicine, Oncology, Breast Oncology +13
Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial
Laura M. Spring, Sara M. Tolaney, Geoffrey Fell et al. · Annals of Oncology · 2023 · 77 citations · Full text
Medicine, Oncology, Pharmacology +17
Isocitrate Dehydrogenase 1 (<i>IDH1</i>) Mutation in Breast Adenocarcinoma Is Associated With Elevated Levels of Serum and Urine 2-Hydroxyglutarate
Amir T. Fathi, Hossein Sadrzadeh, Amy Comander et al. · The Oncologist · 2014 · 74 citations · Full text
Medicine, Molecular Genetics, Oncology +12
1–5 of 13